跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版

Evan Anderson

EA

Evan Anderson

Moderna, USA

Talk Title: RSV Prevention in Adults

Evan J. Anderson is the Executive Director, Infectious Disease Epidemiology, at Moderna. He graduated summa cum laude from Wheaton College, IL after which he pursued his medical degree at the University of Chicago Pritzker School of Medicine. He remained at the University of Chicago for residency in both internal medicine and pediatrics. Subsequently he completed a combined adult and pediatric infectious diseases fellowship at Northwestern Memorial and Children’s Memorial Hospitals in Chicago. He is board certified in internal medicine, adult infectious diseases, pediatrics and pediatric infectious diseases and split his clinical care between adults and children. He moved from Northwestern to Emory University in 2012. He served as the lead investigator in Georgia for influenza, RSV, and COVID-19 surveillance for the CDC-funded Emerging Infections Program. He was one of the multiple PIs of the Emory University Vaccine and Treatment Evaluation Unit (VTEU) and has been intricately involved with COVID-19 vaccine clinical trials in adults and children. While at Emory University School of Medicine, he rose to the rank of a full Professor of Pediatrics and Medicine. In 2023, he transitioned from Emory to a new role leading the Infectious Disease Epidemiology group at Moderna. He has over 250 total publications with particular interest in rotavirus, RSV, influenza, COVID-19, vaccine clinical trials, immunology, and epidemiology.